← SynDRA
SBE13 hydrochloride
SynDRA canonical compound SYN0980545 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PLK1 |
|---|
| Mechanism of action | PLK inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- BAZ2B
- EHMT2
- GMNN
- GNAS
- KDM4A
- KDM4E
- SMN1
Cross-references
Synonyms
- SBE13
- SBE-13
- AP-970/42896634
- orb1687452
- SBE13?
- SCHEMBL25238376
- SCHEMBL29543262
- AGB29482
- BDBM50595387
- HY-15158A
- STK510569
- AKOS001477410
- CS-3786
- NCGC00386430-01
- NCGC00386430-08
- DA-67459
- T62591
- CSB53215
- HY-15158
- SBE-13 HCl;SBE13 HCl
- T2271
- SBE13 (Hydrochloride)
- MLS000538104
- C24H28Cl2N2O4
- DA-77722
- SMR000161652
- SBE13; SBE 13; SBE13; SBE-13 HCl
- AC-35432
- SCHEMBL18797681
- CCG-269537
- AKOS024458077
- s7720
- SCHEMBL31456607
- SBE-13 HCl
- CS-3785
- AS-57127
- SBE 13 hydrochloride?
- SCHEMBL29594940
- orb1305840
- SBE 13 hydrochloride
Look up SBE13 hydrochloride in the interactive SynDRA portal →